Overview
- After Olivia Munn’s 2023 luminal B diagnosis, she urged her mother to take the Tyrer-Cuzick Breast Cancer Lifetime Risk Assessment test.
- Kim Munn’s 26.2% risk score exceeded the 20% high-risk threshold, leading Olivia to insist on an MRI despite a clear mammogram.
- The MRI detected Stage 1 HER2-positive cancer and Kim Munn subsequently underwent a double mastectomy.
- Kim Munn has completed 12 rounds of chemotherapy and will continue monthly Herceptin infusions through the fall.
- Olivia Munn is amplifying calls for women to begin risk assessments at age 30 and to combine mammograms with MRI when scores top 20%.